Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!
SIG Group: SIG platziert Schuldscheindarlehen in Höhe von EUR 450 Millionen bei starker Nachfrage von Investoren! Newron Pharmaceuticals veröffentlicht überzeugende Daten, welche die Wirksamkeit von Evenamide in Zulassungsstudie bei Schizophrenie-Patienten mit geringer Therapieansprache belegen!
Ad-Hoc-Meldung: E.ON bestätigt Ausblick für 2012; Ausblick für 2013 und Aussagen zu 2015 werden überprüft » Report
Peach Property Group AG: Deutsche Tochtergesellschaft verschiebt Börsengang » Report
Neuemission ZKB Warrants » Report
ZKB Top Trading Warrants & Mini-Futures » Report
So investiert Jim Rogers... -RBS » Report
Julius Baer Warrants - Top Trading » Report
North America leads shift in global energy balance, IEA says in latest World Energy Outlook » Report
Composite Leading Indicators (CLIs), OECD, November 2012 » Report
Temenos: Renaissance Credit launches lending in the cloud – a first in West Africa » Report
JB Tracker-Zertifikat auf den 2012 Laggards Basket » Report
Novartis new two-year data with Certican® shows positive outcomes at 24 months in largest liver transplant trial to date » Report
SGS acquires the Ware Care Group, NL » Report
Alpiq führt Restrukturierungsprogramm weiter » Report
Novartis data show ACZ885 delivered rapid and strong symptom relief while reducing frequency of attacks in two periodic fever syndromes » Report
Zehnder: Verlangsamtes Umsatzwachstum und weiterhin hohe Investitionen » Report
Pargesa: Consolidated results 3Q 2012 (unaudited) » Report
Ein schönes Wochenende
Joint Press Release Board of Governors of the Federal Reserve System, Federal Deposit Insurance Corporation, Office of the Comptroller of the Currency: Agencies Provide Guidance on Regulatory Capital Rulemakings » Report
Neuemissionen ZKB Warrants » Report
Italian authorities lift precautionary hold on Novartis seasonal influenza vaccines » Report
IN ZEICHNUNG: JB Barrier Reverse Convertibles » Report
CREDIT SUISSE NEW ISSUE: 8 Warrants on UBS, 4 Call(s), 4 Put(s) » Report
UBS NEW ISSUE Stable Income & Full Upside: 5% p.a. CHF Kick-In GOAL with Participation on Nestlé, Roche, Zurich Insurance » Report
CREDIT SUISSE NEW ISSUE: 8 Warrants on Zurich Insurance Group, 4 Call(s), 4 Put(s) » Report
UBS issued a new 8.50% p.a. USD Early Redemption Kick-In GOAL on Worst of Nasdaq 100 / Russell 2000 / S&P 500 / S&P/TSE 60 (Valor 11406457) directly in the secondary market.
UBS issued a new 7.00% p.a. CHF Early Redemption Kick-In GOAL on Worst of Euro STOXX 50 / Nikkei 225 / SMI / S&P 500 (Valor 19946174) directly in the secondary market.
IN SUBSCRIPTION: JB Callable Multi Barrier Reverse Convertibles auf Versorger- und Goldminen-Aktien » Report
Credit Suisse: Products in Subscription » Report
Novartis announces update to company's Board of Directors to take effect in February 2013 » Report
Richemont: Changes to senior management » Report
Partners Group: Accelerated book built offering priced at CHF 183 per share allowing Partners Group founders to invest a minimum of CHF 300 million alongside clients and to materially increase the free float » Report
Richemont announces its unaudited consolidated results for the six month period ended 30 September 2012 » Report
“Novartis is focused on innovation to address unmet medical needs for patients,” said Joe Jimenez, CEO, at R&Dday » Report
Mario Draghi, President of the ECB: Introductory statement to the press conference » Report
Neuemission ZKB Strukturierte Produkte » Report
EZB PRESSEMITTEILUNG: Geldpolitische Beschlüsse » Report
Bank of England maintains Bank Rate at 0.5% and the size of the Asset Purchase Programme at £375 billion » Report
Zurich - News Release: Isabelle Welton appointed Group Chief Marketing Officer » Report
BLW - Die Bevölkerung steht zur Schweizer Landwirtschaft » Report
KOF/KOF Konjunkturumfragen vom Oktober: Schlechtere Geschäftslage bei Schweizer Unternehmen » Report